A flow immunoassay for alkylphenol ethoxylate surfactants and their metabolites—questions associated with cross-reactivity, matrix effects, and validation by chromatographic techniques by Badea, Mihaela et al.
A
N
A
LYST
FU
LL PA
P
ER
TH
E
www.rsc.org/analyst
A flow immunoassay for alkylphenol ethoxylate surfactants
and their metabolites—questions associated with
cross-reactivity, matrix effects, and validation by
chromatographic techniques†
Mihaela Badea,a Catalin Nistor,b Yasuhiro Goda,c Shigeru Fujimoto,c Shin Dosho,c
Andrei Danet,a Damiá Barceló,d Francesc Venturae and Jenny Emnéus*b
a Department of Analytical Chemistry, University of Bucharest, Bucharest, Romania
b Department of Analytical Chemistry, Lund University, Lund, Sweden
c Takeda Chemical Industries, Ltd., Life-Environment Company, Tokyo, Japan
d IIQAB-CSIC, Department of Environmental Chemistry, Barcelona, Spain
e AGBAR, Aïgues de Barcelona, Barcelona, Spain
Received 24th February 2003, Accepted 2nd May 2003
First published as an Advance Article on the web 11th June 2003
This paper describes the application and evaluation of a competitive enzyme flow injection immunoassay (EFIIA)
for screening of alkylphenol ethoxylate (APEO) surfactants in different water samples based on a generic
immunoassay system previously developed (see E. Burestedt, C Nistor, U. Schagerlöf and J. Emnéus, Anal.
Chem., 2000, 72, 4171–4177). The detection limits for octylphenol ethoxylates (OPEOs), nonylphenol ethoxylates
(NPEOs), and nonylphenol (NP) were 0.5 µg l21, between 2 and 3 µg l21, and 50 µg l21, respectively, with a
sample throughput of 6 h21 (i.e., for triplicate analysis of each sample). Different OPEOs and NPEOs were highly
cross-reactive within the assay, with sensitivities in the same order of magnitude for all the ethoxylates tested, thus
the result obtained by the EFIIA method could be used as an “alkylphenol ethoxylate index”. No or minor matrix
effects with recoveries between 70–120% for the reference analyte NPEO10 in tap, and surface water, and
acceptable for rainwater, were observed. Influent and effluent surfactant containing wastewater samples were
analysed by EFIIA, LC-MS, LC-Fluoresence (LC-FL), and a commercial microplate ELISA. High recoveries for
different concentrations of APEO10 spiked into a 200 times diluted raw influent and effluent wastewater were
achieved with the EFIIA method, however, the found APEO content of the same diluted wastewater samples,
before spiking, could not be correlated directly to the chromatographic result by any of the immunoassays, and the
possible reasons for this are discussed. The same trend of decreasing APEO content from influent to effluent
wastewater could, however, be followed for all methods employed.
Introduction
Alkylphenolethoxylate (APEO) surfactants are used in a variety
of industrial applications, such as in the manufacturing of pulp
and paper, textiles, paints and coatings, adhesives, leather
products, rubber and plastics, as well as in metalworking (as
lubricants) and agriculture (as emulsifiers, dispersants or
adjuvants for some herbicides).1 Their main use remains
however as detergents, both for household and industrial
applications, because of properties such as relative ionic
insensitivity and high absorptive behavior.2–5
Since APEOs are primarily used in aqueous solutions, they
enter into the environment mainly through sewage and
industrial wastewater treatment plants. Numerous biodegrada-
tion studies of APEOs have been performed, leading to results
that showed variations from zero to complete biodegradation,
depending on the experimental conditions used.6–9 The effi-
ciency to remove alkylphenols (APs) and APEOs during
wastewater treatment depends on the treatment conditions, e.g.
90–97% of APEOs from water can be (bio)degraded under
certain conditions.10
The aquatic toxicity of the APEOs and their breakdown
products has shown to be directly proportional with the
hydrophobicity of the compound. Generally, APs are about one
order of magnitude more toxic than their long chained ( > 10)
ethoxylate counterparts. The toxicity of mono and di-ethoxylate
APEOs is similar to the corresponding AP itself.1 Even though
both nonylphenol (NP) and nonylphenol monoethoxylate
(NPEO1) show relatively high toxicity for aquatic organisms
(i.e., their lethal dose varies between 5 to 500 µg l21 for
different tested organisms),11,12 they are generally considered
minimally toxic to mammals, although they can cause severe
skin and eye irritation.1 However, both APs and short-chain
APEOs have proved to give reproductive and endocrine
disruptive effects,13–21 therefore rapid detection and identifica-
tion of APs and APEOs in the environment is nowadays a
subject of great concern.
The chemical complexity of APEOs and APs (see the general
structure in Fig. 1), which are mixtures of numerous isomers
† Electronic supplementary information (ESI) available: Cross reactivity
data. See http://www.rsc.org/suppdata/an/b3/b302110f/
Fig. 1 General structure of APEOs (a), APs (b), and the chemical structure
of the APEO hapten derivative used for tracer synthesis in this work (c). R
denotes the alkyl chain, i.e., octyl- or nonyl- groups; n: 1–40 ethoxy
groups.
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and oligomers, necessitates a rather complicated analytical
methodology for their isolation, determination and identifica-
tion in water environments. A simplification of the problem is
represented by the development of methods for determination of
surfactants as classes of compounds. Simple, relatively fast and
inexpensive quantitative or semi-quantitative methods based on
titrimetric or spectrophotometric techniques have commonly
been used.22–25 Methods that depend on a spectrophotometric
reaction do, however, not reliably reflect the concentration of
either the individual surfactant types (non-ionic, anionic or
cationic), or the concentration of individual compounds within
a class. Major improvements have been made in the identifica-
tion and quantification of surfactants by gas chromatography-
mass spectrometry (GC-MS)26–28 and high-performance liquid
chromatography (HPLC).29–35
Although these analytical techniques are under constant
improvement, extensive sample cleanup and pre-concentration
is usually necessary before detection. As a direct result, the
sample throughput is generally low and there is a long delay
between the sample collection and the communication of results
back to the sampling site. As a complement to already existing
techniques, there is a continuous need for developing screening
methods that should be technically simple and useful for routine
analysis of a large number of samples. Immunoassay techniques
are potential candidates for fulfilling these requirements due to
the high selectivity of antibodies, the good sensitivity of such
systems and the fact that antibodies can be raised against
virtually any compound. The only APEO immunoassay existing
today is to our knowledge a commercial enzyme linked
immunosorbent assay (ELISA) kit available from Takeda
Chemical Industries, Japan36–38 that also provides kits for other
surfactants and environmental pollutants.39 The results obtained
by different chromatographic techniques and the Takeda
immunoassay kit was compared in a recent inter-laboratory
exercise for the determination of surfactants in water sam-
ples.40
The aim of this work was to adapt a previously developed
generic enzyme flow injection immunoassay (EFIIA)41 for
determination of APs and APEOs, and to study its potential for
selective determination of these analytes in different environ-
mental waters as well as influent and effluent waters from
wastewater treatment plants (WWTPs). The EFIIA results were
compared with those obtained with a commercial ELISA, and
two chromatographic methods.
Experimental
Reagents and chemicals
The anti-APEO antibody (monoclonal, from mouse) used in all
experiments and the APEO hapten (i.e., p-nonylphenoxy-
pentaethoxylate succinic ester, see structure in Fig. 1c), were
from Takeda Chemical Industries, Tokyo, Japan. The APEO
hapten and b-GAL (Roche Biochemicals) were used for tracer
synthesis.
Phosphate buffer saline (PBS, 100 mmol L21) stock solution
was prepared according to the following: 80 g NaCl (Merck,
Darmstadt, Germany), 2 g KCl (Merck), 14.3 g Na2HPO4 2H2O
(Merck) and 3.43 g KH2PO4 (all from Merck, Darmstadt,
Germany) were dissolved in 1 l water, and the pH was adjusted
with either NaOH (Eka Nobel, Bohus, Sweden) or HCl (Merck).
The substrate solution for determination of b-GAL activity of
the tracers was made by dissolving 2-nitrophenyl-b-D-galacto-
pyranoside (2-NPG, Sigma Chemical Co, St. Louis, MO, USA)
in 25 mmol l21 phosphate buffer at pH 6.8, according to the
protocol provided by the supplier of the enzyme. The b-GAL
substrate carrier solution was prepared by dissolving 2-NPG in
10 mmol l21 PBS, pH 7.4. Polyoxyethylenesorbitan mono-
laureate (Tween 20, Sigma Chemical Co., St. Louis, MO, USA)
was used as blocking reagent in all experiments to prevent
unspecific protein adsorption in the system. A 0.1 M glycine
(Sigma) buffer for regeneration of the protein G column was
prepared by dissolution in water and pH adjustment to 2.0 with
hydrochloric acid (Merck).
Nonylphenol decaethoxylate (NPEO10) was kindly provided
by Takeda Chemicals, as 1 mg l21 solution in water, containing
20% methanol. Nonylphenol (NP, Aldrich, Steinheim, Ger-
many) was supplied as a technical mixture of branched isomers.
All the other standards were from Kao Corporation (Barcelona,
Spain).
For studying the influence of different metal ions the
following analytical grade reagents were used: Hg(CH3COO)2
(Fluka, Chemie AG, Buchs, Switzerland), Cu2Cl2 (Fluka),
MnCl2 3 4H2O (Merck), Al(NO3)3·9H2O (Merck), and
Zn(CH3COO)2·2H2O (Merck).
Water produced in a Milli-Q system (Millipore, Bedford,
MA, USA) was used for preparing all standard- and buffer
solutions throughout the work.
Preparation of APEO tracers
Tracers with different hapten densities (i.e., initial ratio 20, 50
and 100 moles APEO hapten derivative (Fig. 1c) per mole b-
GAL) were synthesized according to the following procedure:
N-hydroxysuccinimide activated APEO derivative was pre-
pared by dissolving 2.16 mg (4 µmole) of APEO hapten
derivative, 2.3 mg (20 µmole) of N-hydroxysuccinimide (NHS,
Fluka) and 8.25 mg (40 µmol) of N,NA-dicyclohexylcarbodii-
mide (DCC, Sigma) in 150 µl of dry dimethylformamide (DMF,
Fluka), the mixture was stirred and the reaction was allowed to
proceed for 4 h at room temperature. The resulting precipitate
was removed by centrifugation, while the supernatant contain-
ing the activated APEO derivative was used further for tracer
synthesis. The tracer containing the initial ratio 100 moles
APEO derivative per mole b-GAL was prepared by slowly
adding 50 µl of the NHS activated APEO derivative to 5.4 mg
b-GAL dissolved in 450 µl of 130 mM NaHCO3 (Merck,
Darmstadt, Germany). The tracers with initial molar ratios 50
and 20 APEO derivative per b-GAL were prepared by slowly
adding 50 µl of the NHS activated APEO derivative initially
diluted 1 : 2 and 1 : 5, respectively, with dry DMF to 5.4 mg
each of b-GAL dissolved in 450 µl of 130 mM NaHCO3. All
three mixtures were gently stirred and allowed to react for 12 h
at 4 °C.
The separation of b-GAL labelled APEO tracers from the
non-conjugated NHS-activated APEO derivative was per-
formed by dialysis (dialysis cassettes, MWCO 10,000 Da,
Pierce Chemical Co., Rockford, IL, USA) against 2 l of 10 mM
PBS pH 7.4 during 24 h at +4 °C.
Method and instrumentation
All affinity reactions were performed in off-line mode, by
mixing the antibody, tracer and sample containing the analyte(s)
until establishment of equilibrium. Then, the mixtures were
introduced via a 50 µl injection loop into the flow system (see
Fig. 2) by a fully automated ASTED autosampler (233 XL,
Gilson, Villiers le Bel) equipped with a Rheodyne six-port
injection valve (model 7010, Berkeley, CA). The autosampler
was controlled by a Gilson keypad including the software 720
Sampler Controller, version V2.01. A Peek column (0.3 3 0.5
cm) filled with protein G immobilized on Sepharose (High-
Trap®, Pharmacia Biotech, Bromma, Sweden) was inserted into
the flow system preceding the injection valve. A Gilson
Minipuls 2 (Gilson) four channel peristaltic pump was used for
pumping the carrier of 10 mmol l21 PBS, pH 7.4 also containing
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Tween 20 (0.01%, v/v, if not otherwise stated), and the enzyme
substrate carrier, containing 1.57 mg l21 2-NPG in PBS 10 mM,
pH 7.4 also containing 2 mM MgCl2 (Merck), as previously
optimized in a similar system.41 The two flow carriers were
mixed at the ratio 1 : 1 via a T connection, and the reaction
catalysed by the eluted Ag-b-GAL fraction was allowed to take
place in a knitted Teflon mixing coil of 1875 µl, placed into a in-
house-built water bath, connected to the flow-cell of the UV-
VIS detector (model 204, Spectraphysics, NY).
Antibody dilution curves. These were performed for each
tracer first by incubation of different amounts of antibody [Ab]
with an optimised, minimal and constant amount of tracer
(working tracer concentration [Ag*W], giving a signal to noise
(S/N) ratio of about 150), after the total volume was adjusted to
0.5 ml. After 15 min incubation the solutions were injected into
the flow system in Fig. 2. The antibody-bound tracer and
analyte fractions (AbAg* and AbAg) were trapped inside the
protein G column and the free unbound tracer (Ag*) eluted and
monitored spectrophotometrically at 405 nm. The result was a
decrease of the signal with increasing concentrations of
antibody.
Analyte calibrations. These were obtained by mixing 450 µl
of different concentrations of analyte [Ag] with the [Ag*W] and
the antibody concentration resulting in 50% binding of the
tracer (working antibody concentration [AbW]), obtained from
the antibody dilution curves) in a total volume of 0.5 ml. After
incubation for 15 min, the reaction mixtures were injected into
the flow system. The result was an increase of the signal with
increasing concentrations of analyte.
Optimizations and interference studies
The optimisation of pH, ionic strength, methanol, and Tween 20
content in the assay mixture were performed by testing the
influence of the studied parameter on: (1) the b-GAL activity,
by incubating the [Ag*w] for 15 min with different concentra-
tions of H+, NaCl, methanol or Tween 20, then injection into the
flow system (Fig. 2) and measurement of the residual enzyme
activity; (2) the antibody binding in the absence of the analyte
(zero dose), by mixing the [Ag*w] and [Abw] at different
concentrations of the H+, NaCl, methanol, or Tween 20,
incubating the mixture for 15 min, and then injection into the
flow system. The obtained signal was compared with the one
obtained at optimal conditions.
Recovery tests and analysis of water samples
Tap, rain and surface (Höje Å, Lund, Sweden) water samples
were analysed in the first week after sampling. The samples
were stored at 4 °C and filtered through 0.45 µm filters (type
HA, Millipore) before analysis.
Four samples were collected from the raw influent and the
effluent of two WWTPs, namely Abrera and Martorell, located
close to Barcelona, Spain. The samples were supplemented to a
final concentration of 1% formaldehyde as a preservative, to
avoid bacterial degradation of the organic matter during
shipment. The samples were stored at 4 °C and filtered through
0.45 µm filters (type HA, Millipore) prior to analysis.
Analysis performed by EFIIA and ELISA kit. The matrix
effects of various water samples was tested by first buffering to
a final concentration of 10 mM PBS (i.e., by mixing the sample
with 20 mM PBS in the ratio 1 : 1, v/v), then spiking each
sample with NPEO10 at the desired concentration. When the
sample matrix considerably influenced the result (e.g., the
recovery of the spiked analyte was outside the range
70–120%)42 the sample was additionally diluted with 10 mM
PBS prior spiking. The diluted water samples were further
analysed in the same way as the reference solutions (i.e.,
incubated with the optimum concentrations of antibody and
tracer, etc.).
The calibration and sample analysis using the ELISA test kit
was performed according to the instructions provided by the
manufacturer (Takeda Chemical Industries). Briefly, the proto-
col consisted of the following steps: the reconstituted antigen–
enzyme conjugate (i.e., the APEO hapten in Fig. 1c labelled
with horseradish peroxidase (HRP)) was mixed with either the
standard solution or the water sample, and 100 µl of the
resulting mixture was added into each antibody-coated well of
an ELISA plate. After a 60 min incubation step, the solution was
removed from each well, and the plate was washed with 3 3 1
ml of the reconstituted washing buffer. After drying the plate,
and mixing the chromogen and substrate solutions, 100 µl of the
resulting mixture was dispensed into each well of the plate. The
reaction was stopped after 30 min of incubation at room
temperature by adding 50 µl of the stopping solution. Quantifi-
cation was performed measuring the absorbance of each sample
Fig. 2 Scheme and working principle of the EFIIA system: The sample containing the mixture of analyte, antibody and tracer is incubated off-line until
equilibrium (1), then injected into the main flow stream (2) that passes through the protein G column, where the antibody-bound fractions are trapped (3).
The free analyte and tracer are eluted (4) from the column and mixed with the secondary flow containing the b-GAL substrate 2-NPG (5), forming the product
2-NP in the mixing coil (6), which is detected spectrophotometrically at 405 nm (7). Injection volume: 50 µl; mixing coil volume: 1875 µl; flow rate: 0.375
+ 0.375 ml min21. Otherwise conditions are described in the Experimental section or specified in the different figure and table legends.
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at 450 nm using an ELISA plate reader (EL800, Bio-Tek
Instruments Inc.).
The recovery (R) values were calculated according to the eqn.
(1):
(1)
where CIA is the analyte concentration in the spiked sample
evaluated by interpolation in the standard curve, CIA,0 is the
concentration of analyte in the sample without spiking (i.e., this
was different from zero only in the wastewater samples), and
Cspiked is the calculated concentration of the analyte spiked into
each sample.
Taking into account the possible matrix effects, the evalua-
tion of the APEO-equivalent concentration in the wastewater
samples by immunoassay was realized by a variant of the
standard addition method: each sample was diluted with PBS at
5 different dilution levels (i.e., the sample dilution factor was
between 100 and 1000 times, v/v), and NPEO10 was added to a
final spiked concentration of 5, 10, 25, 50 and 100 µg l21 each.
The APEO-equivalent concentration was evaluated by ex-
trapolation of each new calibration to zero spiked analyte
concentration, and the value obtained was multiplied with the
sample dilution factor.
Liquid chromatography–mass spectrometry (LC-MS)
and liquid chromatography–fluorescence (LC-FL).
Solid-phase extraction (SPE). Prior LC-MS experiments, the
samples were pre-concentrated on LiChrolut C18 (Merck,
Darmstadt, Germany) SPE cartridges within 24 h after sampling
in order to avoid any degradation of target compounds. All SPE
experiments were performed using an automated sample
preparation with extraction columns system (ASPEC XL) fitted
to an external 306 LC pump for the dispensing of samples
through the SPE cartridges and with a 817 switching valve for
the selection of samples, all from Gilson (Villiers-le-Bel,
France). Disposable 3 ml cartridge columns packed with 500
mg of LiChrolut C18 sorbent from Merck were activated and
conditioned first with 7 ml of methanol and then with 3 ml of
HPLC water at a flow-rate of 1 ml min21. Samples (100 ml)
were loaded at a flow rate of 5 ml min21. After pre-
concentration, the sorbents were completely dried (30 min) to
avoid hydrolysis using a Baker SPE 12g apparatus (J. T. Baker,
Deventer, The Netherlands) connected to a vacuum system set
at 215 psi. After drying SPE cartridges were wrapped in an
aluminium foil and kept at 220 °C until analysis (maximum 1
month).
Cartridges were eluted with 2 3 4 ml of methanol. The eluted
solutions were evaporated to dryness under a gentle stream of
nitrogen and reconstituted with methanol to a final volume of 1
ml.
Before LC-FL analysis, 100 ml of each sample were enriched
by SPE (Lichrolut EN, Merck) immediately after collection.
Cartridges were eluted with 2 3 5 ml of methanol :
dichloromethane (9 : 1, v/v) with 5 min between elution steps.
The eluted solutions were reconstituted with acetonitrile : water
containing 14 g l21 sodium perchlorate (4 : 6, v/v) to a final
volume of 0.5 ml.
LC-MS and LC-FL experiments. For the LC-MS experi-
ments, the HPLC system consisted of an HP 1100 autosampler
having a 100 µl loop and an HP 1090 A LC binary pump both
from Hewlett Packard (Palo Alto, CA, USA). The HPLC
separation was achieved on a 5 µm, 250 3 4 mm id C18 reversed
phase column (LiChrospher 100 RP-18) preceded by a guard
column (4 3 4 mm, 5 µm) of the same packing material from
Merck. The injection volume was set at 25 µl and the flow rate
was 1 ml min21.
Nonionic surfactants (OPEOs and NPEOs), detected in
positive ionisation (PI) mode, were separated by gradient
elution using the following mobile phase: solvent A methanol/
acetonitrile (50 : 50, v/v) and solvent B water, both acidified
with 0.5% of acetic acid. The following solvent programming
was used: initial conditions were held linear at 30% A for 3 min,
then linearly increased to 90% A in 10 min, then to 100% A in
10 min, finally kept isocratic for 10 min.
Compounds detected in negative ionisation (NI) mode
(polyethoxylene carboxylate alkylphenols (APECs) and APs)
were separated by ion pair chromatography. The solvent A
consisted of acetonitrile/water (80 : 20, v/v) and solvent B was
water, both containing 5 mM acetic acid and 5 mM triethyla-
mine. The gradient was held linear at 50% A for 5 min and then
increased to 100% A in 15 min, which was held constant for
additional 10 min.
Detection was carried out using a HP 1040 M diode array
UV-VIS detector coupled in series with an LC-MS HP 1100
mass-selective detector, equipped with an atmospheric-pressure
ionization source with an electrospray (ESI) interface, under the
following operating conditions: (PI/NI): drying gas flow 12/11
l min21; drying gas temperature 375/325 °C; nebulizer pressure
55/50 psi, capillary voltage 4500/3500 V and fragmenter
voltage 60/80 V.
Diagnostic ions used for the identification of APEOs were
those corresponding to [M + Na]+: m/z 273–933 (Dm/z 44)
(OPEO1-OPEO15), m/z 287–947 (Dm/z 44) (NPEO1-NPEO15).
The extracts were fortified with 25 µM sodium acetate (5 µl of
5 mM aqueous solution) prior analysis in order to avoid the
possible reduction in APEO ionisation due to insufficient metal
ion availability.
NPEC1, octylphenol (OP), nonylphenol (NP) and linear
benzene sulfonate (LAS) surfactants with a chain length of
10–13 carbon atoms were detected under NI conditions as [M 2
H]2, m/z 263 (OP1EC), m/z 277 (NP1EC), m/z 205 (OP) m/z 219
(NP), m/z 297 (C10LAS), m/z 311 (C11LAS), m/z 325 (C12LAS),
and m/z 339 (C13LAS).
Quantitative analysis was performed in a selected ion-
monitoring mode (SIM) using external calibration. The identi-
fication of target compounds was done in a full scan mode (m/z
100–1000) by matching the retention time and mass spectrum
with authentic standards.
APs, APEOs and LAS were also analysed by LC-FL. The
HPLC system was a Waters Alliance 2690 type (Waters). The
separation was achieved on a 5 µm, 250 3 4 mm id C18 reversed
phase column (LiChrospher 100 RP-18) preceded by a guard
column (4 3 4 mm, 5 µm) of the same packing material from
Merck. The injection volume was set at 40 µl, the flow rate was
1 ml min21 and the following gradient was applied: Acetonitrile
(solvent A) and water containing 14 g l21 NaClO4 (solvent B):
0–3 min 60% B, 23 min 30% B, 26 min 10% B, 30 min 60% B,
32 min 60% B. Detection was carried out using a Waters
Fluorescence Detector 474 at an excitation wavelength of 225
nm, and an emission wavelength of 295 nm. Quantification was
achieved by interpolation of chromatographic areas from
calibration curve built for each target compound (r2 >
0.999).
For comparative purposes, the results obtained by LC-MS
and LC-FL were also expressed as an approximate “APEO
index”, taking into consideration the relative mean cross-
reactivity of different NPEOs, OPEOs, NPECs and NP tested in
the EFIIA. The calculation was performed according to the eqn.
(2):
NPEO10 equiv. = 1.1 3 ([NPEOs] + [NPEC2]) + 2.3 3
[OPEOs] + 0.02 3 ([NP] + [NPEC1]) (2)
NPEO10 equiv. is the calculated “APEO index”, expressed in
number of equivalent nonylphenol decaethoxylate concentra-
tion (µg l21), while [NPEOs], [NPECx], [OPEOs], and [NP] are
the corresponding concentrations (in µg l21) of the total
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nonylphenol polyethoxylates, polyethoxylene carboxylate al-
kylphenols with x = 1 or 2 ethoxy groups, total octylphenol
polyethoxylates, and nonylphenol, respectively.
Results and discussion
EFIIA optimization
The flow rate, substrate concentration/reaction time, pH,
temperature, concentration of salt and blocking agent were
optimized and found to give similar optimum conditions as
previously found, proving the generic nature of this type of
system.1 All experiments were thus performed at room
temperature with a carrier of 10 mM phosphate buffer at pH 7.4,
containing 75 mM NaCl, and 0.01% (v/v) Tween 20 (PBST), a
substrate carrier, containing 1.57 mg l21 2-NPG and 2 mM
MgCl2 in PBST, both delivered at a flow rate of 0.375 ml min21
with a b-GAL-substrate reaction time of 2.5 min and product
detection at 405 nm.
Hapten density. b-GAL is a large protein (MW 540 kDa)
with many possible conjugation sites, so that the number of
APEO groups per enzyme molecule can vary depending on the
initial molar ratio used between reactants. The antibody
recognition of the tracers, synthesized starting from different
amounts of APEO hapten derivative and b-GAL (i.e., 20, 50 and
100 moles APEO derivative per mole b-GAL), was studied. The
best recognition was observed for the tracer having the highest
hapten density, and the affinity for the tracer decreased with the
decrease in the APEO derivative/b-GAL molar ratio (results not
shown). The enzyme activity was, however, negatively affected
by the increase in hapten density (i.e., 73%, 40% and 22% from
the initial b-GAL activity was recovered for the tracers with the
initial density of 20, 50 and 100 moles hapten per mole b-GAL,
respectively), probably because of the changes in the folding of
the protein structure and alteration of the b-GAL catalytic site
when many APEO residues are covalently coupled to the
protein molecule. Since the tracer obtained from an initial
APEO derivative density of 100 moles APEO derivative per
mole b-GAL led to the lowest antibody consumption for the
assay development (results not shown), this was the tracer
considered for further experiments as a compromise between
the b-GAL activity and antibody recognition.
Content of methanol in the sample. APEOs exhibit a
number of interesting properties related to their solution phase
behaviour, and their “cloud point” is probably one of the most
important for their use as surfactants. The “cloud point” is
defined as the temperature above which an aqueous solution of
water-soluble non-ionic surfactant becomes turbid,1 and its
value is strongly influenced by pH, salt content and concentra-
tion of surfactant. In normal aqueous environment, the “cloud
point” decreases with the decrease in ethoxylate chain length
(e.g., from 63 °C for nonylphenol decaethoxylate, NPEO10, to
20 °C for nonylphenol heptathoxylate, NPEO7, and from 65 °C
for Triton X-100, OPEO10 to 22 °C for Triton X-114, OPEO8,
while the APEOs with a number of ethoxylate chains less than
6 are virtually insoluble at room temperature).41 It is obviously
very important for immunoassay development to increase the
solubility of the APEOs in order to enhance their interaction
with the corresponding antibody and to improve the assay
sensitivity. One way to achieve this is by addition of small
amounts of a polar organic solvent, in which APEOs are highly
soluble.1
Fig. 3 shows the effect of methanol content in the sample on
both the signal for the b-GAL activity of the tracer alone (index
1) and the signal for the antibody–tracer recognition, with the
contribution from the tracer signal alone subtracted (index 2).
For the assay under study the increase in the concentration of the
methanol leads to a corresponding enhancement of the b-GAL
activity up to around 20%, a point where the signal levels off.
The antibody-tracer recognition follows the same trend until
about 20% methanol, after which the antibody binding of the
tracer is inhibited. In a different experiment, an NPEO10
calibration curve was performed at different concentrations of
methanol. The increase in the concentration of methanol causes
an improvement in IC50, however the precision of the
measurement is also strongly affected (see Table 1), which in
turn affects the final sensitivity of the assay.43 This can be due
to that polar organic solvents disrupt both the antibody-tracer
recognition and the protein G–antibody interactions (which is
why they are often employed as components of the buffers used
for “regeneration” of protein G-based affinity columns), so that
the amount of bound tracer is lower and the separation of the
free tracer fraction from the antibody-tracer complex is less
efficient. A concentration of 5% methanol in the sample was
considered to be sufficient in order to obtain satisfactory
immunoassay sensitivity and precision, as well as good
separation of the labelled fractions.
EFIIA characteristics
The signal given by all tracers was stable at room temperature
for at least 4 h of continuous operation at room temperature,
after which a slow decrease of the signal with time was
observed. However, when a new tracer solution was prepared
from the stock solution (kept at 4 °C), the initial signal was
regained. Due to dispersion in the EFIIA, decrease in the signal
Fig. 3 Influence of the methanol content in the sample on the b-GAL
activity of the tracer (1) and antibody binding (2) [Ab]w = 0.8 mg l21, and
[Ag*]w = 320 µg l21. Carrier: 10 mM phosphate buffer pH 7.4, containing
150 mM NaCl, and 0.01% (v/v) Tween 20 (PBST). Substrate carrier: 1.57
mg l21 2-NPG in PBST, also containing 2 mM MgCl2. Otherwise,
conditions as in Fig. 2.
Table 1 Effect of the methanol content in the sample on the immunoassay
sensitivity (i.e., IC50) and precision. Reference analyte: NPEO10; antibody
concentration 0.8 mg l21. CV is the mean coefficient of variation.
Conditions: as in Fig. 3
Methanol
(% v/v) IC50 CV (%)
0 115 1.2
5 36.5 3.1
10 28.4 7.4
15 16.4 11.2
20 3.5 35.5
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of about 10% was observed when the b-GAL tracers were
passed through the protein G column in comparison with the
signal obtained when the column was by-passed.
Evaluation of the optimised immunoassay and cross-
reactivity studies. The EFIIA was evaluated in terms of
sensitivity, precision and selectivity with the main character-
istics for the reference analytes NPEO10 and NP shown in Table
2. The assay shows a good precision within the quantification
range, and the limit of detection (LOD) for both NPEO10 and
NP is satisfactory for application as screening method for
environmental water samples.
The sensitivity is generally better (i.e., the IC50 value in nM
decreases), when the ethoxylate chain length is increased, and is
superior for an OPEO than a NPEO with the same ethoxylate
chain length (see the electronic supplementary information
(ESI) to the paper for details†). However, from the analytical
point of view, an interesting aspect is that the analytes can be
separated in two different classes as a function of their
sensitivity and CR in the assay: (1) APEOs and APECs with
more than one ethoxylate group (CR ≈ 100%, calculated from
IC50 values in µg l21)(thus an “APEO index”), and (2) APs and
APEC with one ethoxylate group (CR ≈ 2%).
Effect of the sample matrix components on the
immunoassay
Table 3 shows the influence of different water sample matrices
on the sensitivity and precision of the EFIIA for NPEO10. As
seen, the sensitivity was similar in PBST, tap and surface water
and with good recoveries, while the one performed in rainwater
was about 30% more sensitive. The recovery in rainwater was
still within the acceptable limits (between 70–120%) as
recommended by the guidelines published by US EPA for
analysis of environmental samples.42 Thus, the developed
immunoassay could be used without any pre-treatment step for
the estimation of APEO content in these environmental water
samples.
When even more complex wastewaters were analysed, a
dilution of the samples of 100–200 times with the carrier buffer
was necessary prior analysis in order to minimise the matrix
effects and to obtain recovery values of spiked NPEO10 between
70–120%. The obtained recoveries for different spiked concen-
trations were between 70–113% (Table 4) for the EFIIA and
when the spiked real concentrations were plotted vs. the found
values, the slopes varied between 0.95–1.1, as shown in Fig. 4.
The wastewater matrix influenced less the results obtained
using the commercial ELISA kit, with recoveries within
70–120% obtained for sample dilution factors of only 10–50 (v/
v) (results not shown). The reason for less pronounced matrix
effects in the ELISA is due to that here the bound tracer is
measured, i.e., there is a time separation between sample
application and detection, whereas in the EFIIA the matrix
elutes simultaneously with the detected tracer, and thus the
EFIIA is more prone to interferences.
The content of APEOs, APECs and APs in the unspiked
influent and effluent of two WWTPs was evaluated both by the
developed EFIIA, the commercial microplate ELISA, and by
chromatographic techniques. The concentration of the target
analytes determined by LC-MS and LC-FL are presented in
Table 5. The NPEO content in the Abrera and Martorell
influents is generally high, and the concentrations are con-
siderably reduced in the effluents due to the chemical and
biological treatment in the two WWTPs.
Table 2 The main characteristics of the EFIIA for NPEO10 and NP.
Conditions: as in Fig. 3
NPEO10
Assay 1 Assay 2 Assay 3 NP
Calibration points (N) 13 11 11 14
Replicates 3 3 3 3
LODa/µg l21 2.40 ± 0.2 2.55 ± 0.2 2.38 ± 0.2 51 ± 2
DRb/µg l21 5–250 5–250 5–250 100–5000
IC50c/µg l21 26.5 ± 0.5 25.1 ± 0.4 24.9 ± 0.4 963 ± 39
% CVd intra-assay 1.43 1.27 1.27 1.44
% CVd inter-assay 2.68 nd
a The limit of detection (LOD) was estimated as the concentration of the
analyte that gives a change in signal equal to 3 times the standard deviation
of the signal at zero dose (i.e., 1.03% for 21 replicates). b The dynamic range
(DR) was approximated between the analyte concentrations that led to a
relative change in signal of 20 and 80%, respectively, when compared with
the zero dose. c Inhibition concentration at 50% binding (IC50) is the analyte
concentration which leads to 50% change in signal vs. the response in the
absence of the analyte. d The mean CV (%) was calculated in each case only
within the dynamic range of the response. nd–not determined.
Table 3 Effect of the sample matrix on the immunoassay sensitivity and precision of spiked NPEO10. Abbreviations: as in Table 2. Conditions: as in Fig.
3
Spiked Concentration/µg l21
10 25 50 70 100
Sample
IC50/
µg l21 CV (%) Recovery (%)
Standard buffer 24.5 1.44 100.0 100.0 100.0 100.0 100.0
Tap water 24.8 1.96 103.1 101.8 98.6 91.8 118.2
Surface water 23.5 3.45 97.4 91.0 112.0 106.7 113.3
Rain water 16.7 4.50 114.8 86.9 108.4 86.1 100.1
Table 4 Recovery of NPEO10 from spiked wastewater samples analysed by EFIIA
Spiked concentration/µg l21
5 10 25 50 100
Sample Dilution v/v
Slope
(see Fig. 4) Recovery (%)
Martorell, influent 200 1.06 70.0 85.0 108.0 105.0 105.2
Martorell, effluent 200 0.96 110.0 80.0 95.2 104.0 95.0
Abrera, influent 200 1.10 84.0 83.0 107.2 113.0 108.6
Abrera, effluent 200 0.95 88.0 109.0 102.4 91.2 106.2
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The APEO index (expressed in µg l21 as NPEO10, equiva-
lents) evaluated by the different methods (the APEO index for
chromatographic data was calculated according to eqn. (2)) was
significantly higher for the immunoassays than for the chroma-
tographic methods (see Fig. 5), and the effect of overestimating
the APEO content was dependent on the immunoassay format
employed. As already reported, these differences cannot be due
to the high content of LAS (Table 6), since these compounds do
not cross-react with the APEO binding in ELISA.40 The
difference between the EFIIA and ELISA, in addition to the
difference in assay format, is due to two different enzyme labels
being used, i.e., b-GAL in EFIIA and HRP in microplate
ELISA. A pre-cleaning step by solid phase extraction (SPE) is
recommended by the ELISA kit manufacturer to reduce the
matrix effects. However, some previous studies have demon-
strated a reduction of the analyte recovery from samples
analysed by immunoassay after an SPE step vs. without sample
pre-treatment.44,45
Since the recoveries for NPEO10 in the immunoassays were
quite good, the overestimation of the APEO content by the two
immunoassays vs. the chromatographic methods (Fig. 5), might
be due to the methods actually measuring different things, e.g.,
the CR of the immunoassays have only been tested on
structurally related compounds and with those standards that
were available. In principle the CR could be substantially
greater, however the testing of all compounds by any method is
technically impossible. Moreover, the accuracy of determining
APEOs by chromatographic methods is highly dependent on the
availability of the necessary standard materials, the similarity
between the oligomer composition in the reference and the
samples analysed (i.e., the relative response factor of individual
oligomers generally depends on the molecular weight of the
compound analysed and the possible co-elution of the analytes),
and the complexity of the sample matrix. The results seen in Fig.
5, obtained by the different methods (i.e., EFIIA, ELISA, LC-
MS and LC-FL), simply reflect these differences. Nevertheless,
a similar trend from influent to effluent wastewater of the two
WWTPs can be seen for all methods, showing a decrease in
APEO index during the treatment process.
Conclusions
This paper presents the application and evaluation of an EFIIA
for determination of AP and APEOs in different water matrices.
Despite good recoveries for the reference analyte NPEO10 in
matrices such as tap, surface, and rainwater, as well as in diluted
wastewaters, this paper demonstrates the problems associated
with immunoassay techniques in general when trying to
correlate sample analysis results with those obtained with
chromatographic reference methods, also previously ob-
served.46,47
The EFIIA and a commercial ELISA kit substantially
overestimated the content of APEOs and APs in wastewaters
when compared to results obtained by LC-MS and LC-FL.
Although the quantitative correlation between the methods was
relatively poor, it was shown that the immunoassays could be
Fig. 4 Recovery of NPEO10 from spiked wastewater samples by EFIIA.
Spiking levels: 5; 10; 25; 50, and 100 µg l21 NPEO10. Conditions: as in Fig.
3.
Table 5 Analysis of wastewater samples by LC-MS and LC-FL. Conditions, as specified in the Experimental section. Other symbols: nd: not detectable;
LAS–linear alkylbenzene sulfonate. All results are in µg l21.
Martorell Abrera
Influent Effluent Influent Effluent
Compound LC-MS LC-FL LC-MS LC-FL LC-MS LC-FL LC-MS LC-FL
NPEOs 335 208 23 25 2460 844 26.6 24
OPEOs 4.2 nd 0.63 nd 20 nd 0.54 nd
NPEC1 108 nd 6.3 nd 635 nd 7.6 nd
OPEC1 nd nd 1.9 nd 15 nd nd nd
OP nd nd nd nd 1.20 nd nd nd
NP 1.8 58 1.2 1.8 24 748 nd 2.75
Total LAS 1922 2062 24.6 46 1310 1223 45.1 43
Fig. 5 Quantification of the NPEO10 equivalents in wastewater samples
with EFIIA, ELISA, LC-MS, and LC-FL. Conditions: for EFIIA as in Fig.
3, otherwise, see text for details.
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applied for a qualitative evaluation of cleaning efficiency in
WWTPs.
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